| Primary information |
|---|
| CancerPPD ID | 4022 |
| PMID | 16722632 |
| YEAR | 2006 |
| SEQUENCE | YGGFMA* |
| LENGTH | 6 |
| NAME | 23 |
| C-ter Modification | Free |
| N-ter Modification | Free |
| Linear/Cyclic | Linear |
| L/D/Mix | L |
| Non-Natural | A* = Cαα -dialkylated glycine (Aaa1,1 ) |
| NATURE | Antitumor |
| ACTIVITY | 34.4% inhibition at 10-3M |
| SOURCE | Synthetic Peptide |
| Cancer Type | Skin Cancer |
| ASSAY | MTT/MTS assay |
| Patent ID | None |
| Tissue | Skin |
| CELL LINE | HBL |
| TEST TIME | 31.92-Min |
| Secondary information |
|---|
| STRUCTURE | |
| DSSP states | NA |
| SMILES | NA |
| External Links |
|---|
| PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
| NA | NA | NA | NA | NA | NA | NA | NA |
|